About Innovassynth Technologies
Innovassynth Technologies is a Healthcare company based in Mumbai (India) founded in 1964. It operates as a contract research, custom synthesis, and manufacturing services are provided. The company has 293 employees. Its Indian entity Innovassynth Technologies (India ) Limited reported revenue of ₹118 Cr. Innovassynth Technologies offers products and services including Nucleosides, Specialty Chemicals, and Contract Manufacturing. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its competitors include Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma and 5 more; 4 of its 10 listed competitors have raised funding.
Company details
Innovassynth Technologies (formerly known as Chemicals Division of Indian Organic Chemicals) is engaged in contract research, custom synthesis and contract manufacturing. Business segments include Pharma intermediates, protected nucleosides and amidites, protected amino acids for peptide synthesis, fine chemicals and nutraceuticals. It has also set up a cGMP pilot plant facility where 10-15 Kg batch size production is possible and is going for US FDA approval in near future. The company claims to have more than 45 customers in USA, Europe and Japan for its contract manufacturing business.
- Headquarters Mumbai, India
- Employees 293
- SectorsHealthcare
- Website innovassynth.com
- Social LinkedIn YouTube
- Legal Name Innovassynth Technologies (India ) Limited
- Date of Incorporation 04 Dec, 2001
- Jurisdiction Khopoli, Maharashtra, India
- Annual Revenue₹118 Cr
FY 2025 · -27% YoY
- Net Loss-₹13.94 Cr
FY 2025 · -12% margin
- EBITDA-₹4.67 Cr
FY 2025 · -4% margin
- Employee Count293
Associated legal entities of Innovassynth Technologies
Innovassynth Technologies operates through Innovassynth Technologies (India ) Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Innovassynth Technologies (India ) Limited CIN U24110MH2001PLC134105 | Active | 04 Dec 2001 | Khopoli, Maharashtra | ₹118 Cr | 293 | 7 | View details |
Products & Services of Innovassynth Technologies
Innovassynth Technologies offers a comprehensive portfolio of products and services, including Nucleosides, Specialty Chemicals, and Contract Manufacturing.
Products for nucleic acid chemistry and manufacturing services
Custom development of organometallics and polymers additives
Full-scale manufacturing for pharma and chemical intermediates
Apps and channels of Innovassynth Technologies
its YouTube channel Innovassynth has 84 subscribers and 1 videos.
Videos from Innovassynth Technologies
The most watched videos on Innovassynth Technologies's YouTube channel, Innovassynth (84 subscribers). Click a video to play it here.
More on Innovassynth.
Board of directors of Innovassynth Technologies (India ) Limited (Innovassynth Technologies)
Innovassynth Technologies (India ) Limited is the primary company behind Innovassynth Technologies. The board of Innovassynth Technologies (India ) Limited currently have 5 directors; the longest-serving is Viren Rajan Raheja, appointed in 2008. 24 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Viren Rajan Raheja DIN 00037592 | Director | 25 Jun 2008 | 18 yrs 3 mo | Innovassynth Technologies (India ) Limited |
| Hardik Mahesh Joshipura DIN 09392511 | Managing Director | 15 Nov 2021 | 4 yrs 11 mo | Innovassynth Technologies (India ) Limited |
| Akshay Rajan Raheja DIN 00288397 | Director | 29 Sep 2022 | 4 yrs | Innovassynth Technologies (India ) Limited |
| Prosenjit Gupta DIN 10278007 | Director | 25 Aug 2023 | 3 yrs 1 mo | Innovassynth Technologies (India ) Limited |
| Ameeta Aziz Parpia DIN 02654277 | Additional Director | 17 Mar 2025 | 1 yr 7 mo | Innovassynth Technologies (India ) Limited |
People of Innovassynth Technologies
4 people are tracked at Innovassynth Technologies (2 in leadership, 2 in team); the tracked headcount is 293.
| Name | Role | Group |
|---|---|---|
| Chief Executive Officer | Leadership | |
Chandrakant Sonawnae | Deputy General Manager Production Head | Leadership |
Chetana Sonawane | Senior Scientist | Team |
Akshay Ambavane | Executive | Team |
Complete people profiles for Innovassynth Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Innovassynth Technologies
Figures of Innovassynth Technologies (India ) Limited, the primary company behind Innovassynth Technologies, for FY 2025. Revenue was ₹118 Cr (-27% year on year). Net loss was -₹13.94 Cr (-12% margin). EBITDA was -₹4.67 Cr (-4% margin). Revenue has grown at a compounded annual rate of -17% over three years and -5% over five years.
- ₹118 CrRevenue · FY 2025 · -27% YoY
- -₹13.94 CrNet loss · -12% margin
- -₹4.67 CrEBITDA · -4% margin
- ₹75.02 CrPaid-up capital
- 293Employees (provident fund records)
- -17%Revenue CAGR, 3 years
- -5%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Innovassynth Technologies (India ) Limited are on its company page.
Detailed financial statements for Innovassynth Technologies
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Innovassynth Technologies
Innovassynth Technologies has 10 listed competitors in our database, 4 of them funded. They include Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| almacgroup.com | 2001 | Craigavon, United Kingdom | $338.8M | 2,109 | Integrated CDMO services for biopharma R&D and manufacturing are offered. | |
| indoco.com | 1947 | Mumbai, India | – | 6,291 | APIs manufacturing and formulation services are provided in therapeutic segments. | |
| concordbiotech.com | 2000 | Ahmedabad, India | – | 1,598 | APIs and enzymes are manufactured through fermentation by the CDMO. | |
| bdrpharma.com | 2003 | Mumbai, India | $88.16M | 1,864 | APIs and finished products are developed and manufactured. | |
| aurobindo.com | 1986 | Hyderabad, India | – | 1,010 | Generic biocatalytic solutions are provided for pharmaceutical applications. | |
| asymchem.com | 1995 | Morrisville, United States | – | 48 | APIs and peptides are developed and manufactured by Asymchem. | |
| seqens.com | 2003 | Ecully, France | – | 44 | Contract manufacturing services for small molecules and peptides are provided. | |
| continuuspharma.com | 2012 | Woburn, United States | $7.73M | 47 | MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | |
| pharm-int.com | 1994 | Hunt Valley, United States | – | 248 | Pharmaceutical dosage forms are manufactured by this CDMO. | |
| aptuit.com | 2004 | Greenwich, United States | $14.23M | – | Contract research and development services for small molecules are offered. |
Detailed competitors of Innovassynth Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Innovassynth Technologies
The website of Innovassynth Technologies (innovassynth.com) receives about 6.8K visits a month.
- Monthly visits6.8K
▲ 248.5% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Innovassynth Technologies (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Innovassynth Technologies
Complete news archive for Innovassynth Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Innovassynth Technologies
Innovassynth Technologies was founded in 1964.
Innovassynth Technologies is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Innovassynth Technologies has 293 employees.
The primary company behind Innovassynth Technologies, Innovassynth Technologies (India ) Limited, reported revenue of ₹118 Cr for FY 2025, down 27% year on year.
Innovassynth Technologies (formerly known as Chemicals Division of Indian Organic Chemicals) is engaged in contract research, custom synthesis and contract manufacturing. Business segments include Pharma intermediates, protected nucleosides and amidites, protected amino acids for peptide synthesis, fine chemicals and nutraceuticals. It has also set up a cGMP pilot plant facility where 10-15 Kg batch size production is possible and is going for US FDA approval in near future. The company claims to have more than 45 customers in USA, Europe and Japan for its contract manufacturing business.
Innovassynth Technologies's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Innovassynth Technologies offers Nucleosides, Specialty Chemicals, and Contract Manufacturing.
Innovassynth Technologies operates through Innovassynth Technologies (India ) Limited.
The legal entities of Innovassynth Technologies currently have 6 directors, including Viren Rajan Raheja, Prosenjit Gupta, Ameeta Aziz Parpia and others.